NCX-L2

N/A

Report date: 2025/06/30 16:48:05

Base Information

Drug NameNCX-L2
Drug Alias NameNCX-L2
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeoclease
China Registration ClassN/A

Develop Information

Active CompaniesNeoclease
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A